Definium Therapeutics
DFTX
#3556
Rank
ยฃ3.10 B
Marketcap
ยฃ28.47
Share price
54.02%
Change (1 day)
476.19%
Change (1 year)

Revenue for Definium Therapeutics (DFTX)

Revenue in 2025 (TTM): N/A

a decrease over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Definium Therapeutics from 2020 to 2025

Annual revenue

Year Revenue Change
2025 N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A